Here, we evaluated an HDAd-EF1α.ABE8e vector in vitro in CD34+ cells from patients with β-thalassemia and SCD, as well as in ex vivo and in vivo HSC gene therapy settings in the β-YAC mouse model. This evidence concerns the gene CD34 and Schnyder corneal dystrophy.